Diagnostic Arthrocentesis for Suspicion of Gout Is Safe and Well Tolerated
2015; The Journal of Rheumatology Publishing Company Limited; Volume: 43; Issue: 1 Linguagem: Inglês
10.3899/jrheum.150684
ISSN1499-2752
AutoresWilliam J. Taylor, Jaap Fransen, Nicola Dalbeth, Tuhina Neogi, H Ralph Schumacher, Melanie Brown, Worawit Louthrenoo, Janitzia Vazquez-Mellado, М. С. Елисеев, Géraldine McCarthy, Lisa K Stamp, Fernando Perez‐Ruiz, Francisca Sivera, Hang‐Korng Ea, Martijn Gerritsen, Carlo A Scire, Lorenzo Cavagna, Chingtsai Lin, Yin-Yi Chou, Anne-Kathrin Tausche, Geraldo da Rocha Castelar Pinheiro, M. Janssen, Jiunn-Horng Chen, Ole Slot, Marco Cimmino, Till Uhlig, Tim L Jansen,
Tópico(s)Musculoskeletal synovial abnormalities and treatments
ResumoObjective. To determine the frequency of adverse events of diagnostic arthrocentesis in patients with possible gout. Methods. Consecutive patients underwent arthrocentesis and were evaluated at 6 weeks to determine adverse events. The 95% CI were obtained by bootstrapping. Results. Arthrocentesis was performed in 910 patients, and 887 (97.5%) were evaluated for adverse events. Any adverse event was observed in 12 participants (1.4%, 95% CI 0.6–2.1). There was 1 case (0.1%, 95% CI 0–0.34) of septic arthritis. Conclusions. Diagnostic arthrocentesis is associated with a low frequency of adverse events. Septic arthritis rarely occurs.
Referência(s)